APA (7th ed.) Citation

ET, M., M, K., K, S., L, A., A, S., & L, F. (2026). Assessing the treatment of pancreatic ductal adenocarcinoma by deuterium metabolic imaging: A preclinical study. Magma (New York, N.Y.), 39(3), 417. https://doi.org/10.1007/s10334-026-01340-z

Chicago Style (17th ed.) Citation

ET, Montrazi, Kovalevsky M, Sasson K, Agemy L, Scherz A, and Frydman L. "Assessing the Treatment of Pancreatic Ductal Adenocarcinoma by Deuterium Metabolic Imaging: A Preclinical Study." Magma (New York, N.Y.) 39, no. 3 (2026): 417. https://doi.org/10.1007/s10334-026-01340-z.

MLA (9th ed.) Citation

ET, Montrazi, et al. "Assessing the Treatment of Pancreatic Ductal Adenocarcinoma by Deuterium Metabolic Imaging: A Preclinical Study." Magma (New York, N.Y.), vol. 39, no. 3, 2026, p. 417, https://doi.org/10.1007/s10334-026-01340-z.